Lawrence A. Kenyon
CHIEF FINANCIAL OFFICER at Outlook Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Outlook Therapeutics Inc., 2 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Outlook Therapeutics Inc. March 7, 202496.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 14, 2026 | Outlook Therapeutics Inc. | Open-market purchase | +101,010 | — | — |
| Sep 26, 2024 | Outlook Therapeutics Inc. | Open-market purchase | +5,000 | $5.69 | $28,450 |
Questions about Lawrence A. Kenyon
What boards is Lawrence A. Kenyon on?
Lawrence A. Kenyon sits on the board of Outlook Therapeutics Inc.
How long has Lawrence A. Kenyon served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.